日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Label extension, single-arm, phase III study shows efficacy and safety of stempeucel® in patients with critical limb ischemia due to atherosclerotic peripheral arterial disease

标签扩展、单臂、III期研究表明，stempeucel® 对因动脉粥样硬化性外周动脉疾病引起的严重肢体缺血患者有效且安全。

期刊:Stem Cell Research & Therapy
影响因子:7.3
doi:10.1186/s13287-023-03292-w
Gupta, Pawan Kumar; Shivashankar, P; Rajkumar, M; Mahapatra, Subhendu S; Desai, Sanjay C; Dhar, Anita; Krishna, Vinay; Raviraja, N S; Bhat, Samatha; Viswanathan, Pachaiyappan; Kannan, Suresh; Abraham, Jijy; Boggarapu, Hema; Manjuprasad, M S; Udaykumar, K
心血管
动脉粥样硬化
发表日期：2023
文献求助 收藏

Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger's disease.

IV 期上市后监测研究表明，Stempeucel 对因布尔格氏病引起的严重肢体缺血患者持续有效且安全

期刊:Stem Cells Translational Medicine
影响因子:4.9
doi:10.1002/sctm.21-0197
Gupta Pawan Kumar, Dutta Santanu, Kala Sanjay, Nekkanti Muralikrishna, Desai Sanjay C, Mahapatra Subhendu S, Dhar Anita, Raju Radhakrishnan, M Rajkumar, Behera Arunanshu, P Shivashankar, Raviraja N S, Viswanathan Pachaiyappan, Chandrashekar Mithun, Thej Charan, K V Prasanth, Abraham Jijy, Boggarapu Hema, Udaykumar K
其它
发表日期：2021
文献求助 收藏

Administration of Adult Human Bone Marrow-Derived, Cultured, Pooled, Allogeneic Mesenchymal Stromal Cells in Critical Limb Ischemia Due to Buerger's Disease: Phase II Study Report Suggests Clinical Efficacy

成人人骨髓来源、培养、混合、异体间充质干细胞治疗血栓闭塞性脉管炎引起的严重肢体缺血：II期研究报告显示其具有临床疗效

期刊:Stem Cells Translational Medicine
影响因子:4.9
doi:10.5966/sctm.2016-0237
Gupta, Pawan K; Krishna, Murali; Chullikana, Anoop; Desai, Sanjay; Murugesan, Rajkumar; Dutta, Santanu; Sarkar, Uday; Raju, Radhakrishnan; Dhar, Anita; Parakh, Rajiv; Jeyaseelan, Lakshmanan; Viswanathan, Pachaiyappan; Vellotare, Prasanth Kulapurathu; Seetharam, Raviraja N; Thej, Charan; Rengasamy, Mathiyazhagan; Balasubramanian, Sudha; Majumdar, Anish S
发育与干细胞
心血管
Human
干细胞
细胞生物学
发表日期：2017
文献求助 收藏

Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel®): preclinical and clinical trial in osteoarthritis of the knee joint

成人骨髓来源、培养、混合的同种异体间充质干细胞（Stempeucel®）治疗膝关节骨关节炎的疗效和安全性：临床前和临床试验

期刊:Arthritis Research & Therapy
影响因子:4.6
doi:10.1186/s13075-016-1195-7
Gupta, Pawan Kumar; Chullikana, Anoop; Rengasamy, Mathiyazhagan; Shetty, Naresh; Pandey, Vivek; Agarwal, Vikas; Wagh, Shrikant Yeshwant; Vellotare, Prasanth Kulapurathu; Damodaran, Devi; Viswanathan, Pachaiyappan; Thej, Charan; Balasubramanian, Sudha; Majumdar, Anish Sen
关节炎
发育与干细胞
干细胞
细胞生物学
发表日期：2016
文献求助 收藏